Orion Market Research
Global EPO Biomarkers Market Research and Forecast 2018-2023
HEALTHCARE
&
MEDICAL DEVICES
DEFINITION
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow.
MARKET MOTIVATORS
• INCREASING INCIDENCE OF CANCERS AND RENAL DISORDERS • SEDENTARY LIFESTYLE AND FAULTY DIETARY HABITS • INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASES SUCH AS DIABETES • UPCOMING PATENT EXPIRATION OF EPO BIOMARKERS
MARKET RESTRAINTS
LESS OF QUALITY CONTROL TESTING LABORATORIES IN EMERGING ECONOMIES
MARKET OPPORTUNITIES
FAVORABLE HEALTHCARE REGULATIONS IN EMERGED ECONOMIES
REGIONAL ANALYSIS
REGIONAL ANALYSIS 10%
40%
25%
1 25%
North America
Europe
APAC
RoW
REGIONAL ANALYSIS
REGIONAL ANALYSIS 10
40
25
25
North America
Europe
APAC
RoW
MARKET SEGMENTATION GLOBAL EPO BIOMARKER MARKET, BY END USERS
Diagnostic centers Ambulatory care and surgical centers Hospitals
COMPANY PROFILE 3SBIO GROUP AGILENT TECHNOLOGIES, INC. AMGEN INC. BIOAGILYTIX LABS BIOCON BIO-RAD LABORATORIES, INC. EVE TECHNOLOGIES F. HOFFMANN-LA ROCHE LTD GALENICA AG GENSCRIPT To Be Continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010
Global +1 646-755-7667 Asia +91 917-982-8694
info@omrglobal.com https://www.omrglobal.com
https://www.omrglobal.com/industry-reports/epo-biomarkers-market/